"After all, nothing says 'safety net' quite like five publicly traded mega-corporations capturing 77% of all 340B contract pharmacy relationships." @DrugChannels
https://t.co/SQJEilRyzg
#DYK that an insured patient may pay coinsurance based on a drug’s full list price, even if the hospital acquired it at a steep discount through #340B. The patient’s out-of-pocket cost may even exceed what the hospital paid for the drug in the first place. https://t.co/wQjlWIPCw8
This morning, the National Grange launched a new report, "The 340B Program Impact on Rural Hospitals," which reveals stark disparities between rural and non-rural hospitals and raises concerns about policy and structural challenges that threaten the stability of rural healthcare systems.
We urge policymakers to make 340B reforms that ensure discounted drug savings while protecting program eligibility to true rural hospitals and rural demographics.
Learn more here: https://t.co/l7T55eqoCn.
#340B #RuralHealth #RuralHospitals
WATCH: @FoxBusiness highlighted abuses in the #340B program that let large hospitals mark up drug prices and pocket the savings.. Congress must reform 340B to protect patients and preserve private practice.
https://t.co/P20fB8tNsz
Thank you @SenThomTillis for stressing the importance of innovation and the harmful effects of price controls on the development of new cures.
https://t.co/1aLDDmGJB8
The @WaysandMeansGOP held a hearing on the impact of rising health care costs on patients and families.
We have to have serious reform of health insurers, pharmacy benefit managers, and their subsidiaries to reduce the cost of healthcare.
Thank you to @RepDonDavis and @NCLifeSci for pushing North Carolina forward in the life sciences economy and for bringing forth new cures for patients.
Biotech manufacturing, innovation, and research are the pride of North Carolina. @NCLifeSci and its coalition are at the forefront of scientific advancement for the greater good. Congress should focus on providing support, not creating obstacles to growth.
After the SOTU, it’s important to remember that government price-setting risks shifting innovation from the U.S. to other countries that are eager to gain global leadership. More in this op-ed by Rich Bagger of @drugwonks: https://t.co/G08VfbQN8Q
What is a Pharmacy Benefit Manager… and why should you care?
Most people have never heard of a PBM.
But PBMs help decide what you pay at the pharmacy counter.
They sit in the middle of the system, working between:
• Drug manufacturers
• Insurance companies
• Pharmacies
They negotiate rebates.
They help decide which drugs are covered.
They influence how much pharmacies are reimbursed.
Originally, PBMs were meant to help control costs.
But when pricing structures aren’t transparent, it can be hard to understand where the money is going - and why your prescription costs what it does.
If pricing isn’t clear, patients can end up paying more.
Local pharmacies can lose money.
Employers may not see the full picture of what they’re spending.
So here’s the question:
Did you know PBMs influence your prescription costs?
Have you ever been surprised by what you had to pay at the counter?
Let’s talk about it 👇
@SenKatieBritt@SenTuberville@RepTerriSewell@USRepGaryPalmer@RepBarryMoore@RepSCFigures@RepMikeRogersAL@Robert_Aderholt@RepDaleStrong@_Apci@TruthRx@COMMPHARMACY
#PBMReform #DrugPricing #HealthcareTransparency #PatientsFirst #CommunityPharmacy #FairPricing #MedicarePartD
What won’t be covered during the SOTU: Enacting #MFN pricing would threaten progress in onshoring and U.S. competitiveness. Learn more about what’s at stake from @weworkforhealth: https://t.co/dzkA5yJPSg
Price controls hinder innovation and diminish patient access to life-saving cures. President Trump’s push to codify #MFN fails to recognize the threats it poses to the U.S. innovation ecosystem. More from @weworkforhealth: https://t.co/MRO0dZ3Xqs
Under President Trump, the life sciences industry has invested $582B+ into new facilities and R&D efforts in the U.S. Enacting MFN could undercut those investments and force the U.S. to fall behind.https://t.co/ugD8Xcc74Z